Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma

Published:2018-10 Issue:10 Volume:24 Page:2127-2132
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kansagra Ankit^ORCID,Gonsalves Wilson I.,Gertz Morie A.,Buadi Francis K.,Dingli David,Dispenzieri Angela,Lacy Martha Q.,Hayman Suzanne R.,Kapoor Prashant,Muchtar Eli,Kourelis Taxiarchis V.,Warsame Rahma,Leung Nelson,Zeldenrust Steven R.,Lust John A.,Rajkumar S. Vincent,Kyle Robert A.,Hogan William^ORCID,Kumar Shaji K.^ORCID

Funder

National Cancer Institute of the National Institutes of Health

Jabbs Foundation, Birmingham, United Kingdom, the Henry J. Predolin Foundation

National Center for Advancing Translational Sciences

Marion Schwartz Foundation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference23 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Moreau;Ann Oncol,2017